Rex Clements

Algemeen Directeur bij Centrient Pharmaceuticals Netherlands BV

Health Technology

Finance

Actieve functies van Rex Clements

Bedrijven	Functie	Begin	Einde
Centrient Pharmaceuticals Netherlands BV Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands.	Algemeen Directeur	16-03-2020	-
Centrient Holding BV Centrient Holding BV Finance/Rental/LeasingFinance Centrient Holding BV operates as a special purpose entity. The private company is based in Rotterdam, Netherlands. and has subsidiaries in Netherlands. The Dutch company was founded in 1869. Rex Clements has been the CEO of the company since 2020.	Algemeen Directeur	01-03-2020	-

Internationaal

Nederland

Operationeel

Chief Executive Officer

Sectoraal

Health Technology	2
Finance	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	2
Centrient Pharmaceuticals Netherlands BV Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands.	Health Technology
Centrient Holding BV Centrient Holding BV Finance/Rental/LeasingFinance Centrient Holding BV operates as a special purpose entity. The private company is based in Rotterdam, Netherlands. and has subsidiaries in Netherlands. The Dutch company was founded in 1869. Rex Clements has been the CEO of the company since 2020.	Finance

Bedrijven in privébezit

Health Technology

Finance